← All companies

TRIB

Trinity Biotech plc

TRIB Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$11.13

-0.47 -4.09%

Key statistics

from XBRL data in SEC filings

Market cap

$4.16B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$7.94 – $103.20

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 22, 2026 6-K Jul 22, 2026 6-K Jul 2, 2026 6-K Jun 30, 2026 6-K Jun 29, 2026 6-K Jun 23, 2026 6-K Jun 18, 2026 6-K Jun 12, 2026 6-K Jun 5, 2026 6-K May 6, 2026 20-F Apr 30, 2026 6-K Mar 25, 2026 6-K Mar 16, 2026 6-K Mar 10, 2026 6-K Mar 10, 2026 6-K Feb 25, 2026 6-K Feb 20, 2026 6-K Feb 13, 2026 6-K Feb 13, 2026 6-K Dec 23, 2025 6-K Dec 23, 2025 6-K Dec 23, 2025 6-K Dec 18, 2025 6-K Nov 21, 2025 6-K Nov 18, 2025 6-K Oct 23, 2025 6-K Sep 30, 2025 6-K Sep 8, 2025 6-K Sep 2, 2025 6-K Aug 20, 2025 6-K Aug 15, 2025 6-K Aug 12, 2025 6-K Aug 8, 2025 6-K Jul 24, 2025 6-K Jul 1, 2025 6-K Jun 24, 2025 20-F May 16, 2025 6-K May 15, 2025 6-K Apr 4, 2025 6-K Mar 14, 2025